Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Evaxion Biotech A/S

Evaxion Biotech A/S (EVAX) Stock Overview

Explore Evaxion Biotech A/S’s financial performance, market position, analyst ratings, and future outlook.

EVAX●NASDAQ
HealthcareBiotechnology
$3.24
$0.09(2.86%)
U.S. Market is Open · 14:51

Evaxion Biotech A/S (EVAX)

Meyka AI Score

Z

Key Financials

Market Cap19.9M
P/E Ratio-2.11
EPS (TTM)$-1.47
ROE-0.74%
Fundamental Analysis

AI Price Forecasts

1 Month$2.99
3 Months$7.30
1 Year Target$0.00

EVAX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Evaxion Biotech A/S (NASDAQ: EVAX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Evaxion Biotech A/S's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EVAX on the NASDAQ shows an RSI of 57.96, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Evaxion Biotech A/S's NASDAQ-traded stock include a P/E ratio of -2.11 and a market capitalization of 19.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of EVAX on the NASDAQ.

Price Performance (NASDAQ: EVAX)

1-Day Change
N/A
5-Day Change
-4.26%
1-Month Change
2.27%
3-Month Change
-20.85%
6-Month Change
-9.48%
Year-to-Date (YTD) Change
-33.96%
1-Year Change
3.62%
3-Year Change
-93.47%
5-Year Change
-98.84%
All-Time (Max) Change
-99.36%

Contact Information

https://evaxion.ai
45 53 53 18 50
Dr. Neergaards Vej, Horsholm, ND, 2970

Company Facts

460 Employees
IPO DateFeb 5, 2021
CountryDK
Actively Trading

Frequently Asked Questions